These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 622856)

  • 1. [Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
    Fodor GP
    ZFA (Stuttgart); 1978 Jan; 54(1):49-55. PubMed ID: 622856
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of hypertriglyceridemia].
    Wollenweber J
    ZFA (Stuttgart); 1978 Feb; 54(6):349-53. PubMed ID: 636529
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
    Mann S; Maisenbacher HJ
    Z Allgemeinmed; 1975 Aug; 51(24):1066-71. PubMed ID: 1101545
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
    Graham L; Mulcahy R; Hickey N
    Atherosclerosis; 1977 Aug; 27(4):487-92. PubMed ID: 884003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G; Keller C; Kilani S; Zöllner N
    Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
    Dujovne CA; Azarnoff DL; Pentikainen P; Manion CV; Hurwitz A
    Am J Med Sci; 1979; 277(3):255-61. PubMed ID: 222145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug review. Liapten].
    Med Monatsschr; 1975 Oct; 29(10):472-3. PubMed ID: 1223625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia].
    Kleiber G; Leickert KH
    ZFA (Stuttgart); 1979 Jul; 55(21):1199-205. PubMed ID: 157647
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
    Schäfer B; Kluthe R
    Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic activity of a combination of nicotinyl alcohol, vitamin A and vitamin E in atherosclerotic arteriopathies].
    Putignano G
    Clin Ter; 1980 Aug; 94(3):275-82. PubMed ID: 7449347
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and tolerance of a new sustained-release preparation of nicotinic alcohol for reduction of the atherosclerotic risk index].
    Bossini A; Pirro C; Barba C
    Clin Ter; 1984 Sep; 110(5):417-28. PubMed ID: 6238757
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical testing of Danaden retard in functional psychoses from the aspect of slight to medium severe transient syndrome].
    Engelmann G
    Med Welt; 1975 Jul; 26(29-30):1380-4. PubMed ID: 1100984
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
    Lundholm L; Jacobsson L; Brattsand R; Magnusson O
    Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of Clofibrate on disorders in lipid metabolism. I].
    Szybiński Z; Lankosz J; Kieta-Fyda A; Bobrowski A; Biczowa N; Mareczek S
    Przegl Lek; 1971 Oct; 28(10):668-71. PubMed ID: 5136016
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of sound perception deafness with Danaden retard].
    Koeppel FW
    MMW Munch Med Wochenschr; 1976 Aug; 118(32-33):1015-6. PubMed ID: 822295
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
    Zöllner N; Keller C; Wolfram G
    Med Klin; 1976 Apr; 71(18):768-74. PubMed ID: 818496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
    Gniwotta E; Herter B
    ZFA (Stuttgart); 1977 Apr; 53(10):565-8. PubMed ID: 324162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.